The Cigna Group (CI)
What changed in recent filings
- Revenue +7% YoYQuarter ended Jun 30, 2026
- Evernorth segment 79% → 84%Sep 30, 2024 → Jun 30, 2026
- Institutions — 1 new · 2 added · 4 reduced13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
The Cigna Group recent earnings releases
Based on SEC filings. The release date is the day the earnings filing (8-K) was accepted; for quarters where that filing was not found, the periodic report filing date is shown.
- 26Q2Released Jul 30, 2026Revenue +6.7% YoY · EPS $6.29Released before the open: Jul 29 close → Jul 30 close, the stock moved -3.0% · over the same window, market +1.7% · sector -0.9%
- 26Q1Released Apr 30, 2026Revenue +4.6% YoY · EPS $6.26Released before the open: Apr 29 close → Apr 30 close, the stock moved -0.6% · over the same window, market +1.0% · sector +1.0%
- 25Q4Released Feb 5, 2026Revenue +10.4% YoY · EPS $4.66Released before the open: Feb 4 close → Feb 5 close, the stock moved +4.7% · over the same window, market -1.2% · sector -0.4%
- 25Q3Released Oct 30, 2025Revenue +9.5% YoY · EPS $6.98Released before the open: Oct 29 close → Oct 30 close, the stock moved -17.4% · over the same window, market -1.1% · sector +0.0%
The next earnings release is estimated around Oct 29, 2026 (calculated from how long this company has taken between quarter end and filing; it is not a date announced by the company).
Institutions holding The Cigna Group
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 6 → 2026 Q2: 11 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold The Cigna Group
Institutions we track that reported holding this stock in their most recent 13F.
- Pzena Investment Management0.45% of portfolio · held as of 2019 Q1 or earlier
- Glenview Capital Management2.07% of portfolio · held as of 2019 Q1 or earlier
- National Pension Service (Korea)0.14% of portfolio · held as of 2019 Q1 or earlier
- Dodge & Cox1.76% of portfolio · held as of 2019 Q1 or earlier
- Caisse de depot (Quebec)0.28% of portfolio · held as of 2019 Q1 or earlier
- Capital World Investors0.04% of portfolio · held as of 2020 Q3 or earlier
- Bridgewater Associates0.10% of portfolio · since 2021 Q2
- GQG Partners3.03% of portfolio · since 2024 Q3
- Moore Capital Management0.29% of portfolio · since 2025 Q2
- Greenlight Capital0.62% of portfolio · since 2025 Q2
- Tudor Investment CorpNew this quarter0.03% of portfolio · since 2026 Q2
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Q2 2026 13F recap — stocks several institutions bought and sold together →Company overview
The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations. Its offerings include medical, dental, behavioral, disability, and life insurance, along with pharmacy benefit management, specialty pharmacy, care coordination, and other clinical and administrative services. The Cigna Group plays an important role in the healthcare market by connecting insurance coverage with pharmacy and care management capabilities, helping clients and members access coordinated health benefits and services across the United States and selected international markets. Headquartered in Bloomfield, Connecticut, The Cigna Group remains a major diversified healthcare services provider.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
The Cigna Group is classified under the Biotech & Health sector. See peers below.
The Cigna Group key financials
Based on SEC filings · as of Jun 30, 2026
Tap a metric name to see its meaning in the glossary.
The Cigna Group vs Biotech & Health sector benchmark
Median of 38 representative sector stocks · SEC filings · factual comparison (not advice)
A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.
CI revenue by segment summary
SEC 10-Q · segment totals cross-checked against total revenue
2026-06-30 revenue was $71.7B, +6.7% YoY.
The largest segment is Evernorth, 83.7% of revenue — a highly concentrated structure.
Recent revenue growth was led mainly by the Evernorth segment (about 81% of the increase).
Full segment weights, YoY changes, and an AI synthesis are available in the detailed analysis.
CI segment revenue mix trend
Quarterly change in segment revenue share · verified from SEC filings
ETFs holding The Cigna Group
Per SEC N-PORT · 2026-06-30 · by weight · factual
CI on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
CI FAQ
What is The Cigna Group (CI)?
The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations. Its offerings include medical, dental, behavioral, disability, and life insurance, along with pharmacy benefit management, specialty pharmacy, care coordination, and other clinical and administrative services. The Cigna Group plays an important role in the healthcare market by connecting insurance coverage with pharmacy and care management capabilities, helping clients and members access coordinated health benefits and services across the United States and selected international markets. Headquartered in Bloomfield, Connecticut, The Cigna Group remains a major diversified healthcare services provider.
What sector is The Cigna Group in?
The Cigna Group is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are The Cigna Group's key financials?
As of Jun 30, 2026 in SEC filings: Revenue growth (YoY) 7.8%, Operating margin 3.7%, Net margin 2.2%, ROE 14.3%, Debt-to-equity 0.68x. Definitions and interpretation are available on Stocklore.
What are The Cigna Group's main revenue segments?
The largest segment is Evernorth, about 83.7% of revenue. Segment totals are cross-checked against total revenue from SEC filings.
Where can I analyze The Cigna Group (CI) stock?
On Stocklore you can see CI's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.